BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37190306)

  • 1. Ursolic Acid Alleviates Cancer Cachexia and Prevents Muscle Wasting via Activating SIRT1.
    Tao W; Ouyang Z; Liao Z; Li L; Zhang Y; Gao J; Ma L; Yu S
    Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ursolic acid alleviates cancer cachexia by inhibiting STAT3 signaling pathways in C2C12 myotube and CT26 tumor-bearing mouse model.
    Chen L; Chen Y; Wang M; Lai L; Zheng L; Lu H
    Eur J Pharmacol; 2024 Apr; 969():176429. PubMed ID: 38423241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical Investigation of Alpinetin in the Treatment of Cancer-Induced Cachexia
    Zhang Y; Zhang Y; Li Y; Zhang L; Yu S
    Front Pharmacol; 2021; 12():687491. PubMed ID: 34093209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imperatorin alleviates cancer cachexia and prevents muscle wasting via directly inhibiting STAT3.
    Chen L; Xu W; Yang Q; Zhang H; Wan L; Xin B; Zhang J; Guo C
    Pharmacol Res; 2020 Aug; 158():104871. PubMed ID: 32413482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway.
    Chen L; Yang Q; Zhang H; Wan L; Xin B; Cao Y; Zhang J; Guo C
    J Ethnopharmacol; 2020 Oct; 260():113066. PubMed ID: 32505837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-17A contributes to skeletal muscle atrophy in lung cancer-induced cachexia via JAK2/STAT3 pathway.
    Ying L; Yao Y; Lv H; Lu G; Zhang Q; Yang Y; Zhou J
    Am J Physiol Cell Physiol; 2022 May; 322(5):C814-C824. PubMed ID: 35319902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carboxyamidotriazole alleviates muscle atrophy in tumor-bearing mice by inhibiting NF-κB and activating SIRT1.
    Chen C; Ju R; Zhu L; Li J; Chen W; Zhang DC; Ye CY; Guo L
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Apr; 390(4):423-433. PubMed ID: 28124088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
    Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
    Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alantolactone ameliorates cancer cachexia-associated muscle atrophy mainly by inhibiting the STAT3 signaling pathway.
    Shen Q; Kuang JX; Miao CX; Zhang WL; Li YW; Zhang XW; Liu X
    Phytomedicine; 2022 Jan; 95():153858. PubMed ID: 34861585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The MEK-Inhibitor Selumetinib Attenuates Tumor Growth and Reduces IL-6 Expression but Does Not Protect against Muscle Wasting in Lewis Lung Cancer Cachexia.
    Au ED; Desai AP; Koniaris LG; Zimmers TA
    Front Physiol; 2016; 7():682. PubMed ID: 28149280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of heat shock protein (HSP) 90 reverses signal transducer and activator of transcription (STAT) 3-mediated muscle wasting in cancer cachexia mice.
    Niu M; Song S; Su Z; Wei L; Li L; Pu W; Zhao C; Ding Y; Wang J; Cao W; Gao Q; Wang H
    Br J Pharmacol; 2021 Nov; 178(22):4485-4500. PubMed ID: 34265073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia.
    Silva KA; Dong J; Dong Y; Dong Y; Schor N; Tweardy DJ; Zhang L; Mitch WE
    J Biol Chem; 2015 Apr; 290(17):11177-87. PubMed ID: 25787076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ameliorating cancer cachexia by inhibiting cancer cell release of Hsp70 and Hsp90 with omeprazole.
    Liu Z; Xiong J; Gao S; Zhu MX; Sun K; Li M; Zhang G; Li YP
    J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):636-647. PubMed ID: 34729960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HCT116 colorectal liver metastases exacerbate muscle wasting in a mouse model for the study of colorectal cancer cachexia.
    Huot JR; Novinger LJ; Pin F; Bonetto A
    Dis Model Mech; 2020 Jan; 13(1):. PubMed ID: 31915140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological Inhibition of HMGB1 Prevents Muscle Wasting.
    Li L; Liu H; Tao W; Wen S; Fu X; Yu S
    Front Pharmacol; 2021; 12():731386. PubMed ID: 34867338
    [No Abstract]   [Full Text] [Related]  

  • 16. Skeletal muscle glycoprotein 130's role in Lewis lung carcinoma-induced cachexia.
    Puppa MJ; Gao S; Narsale AA; Carson JA
    FASEB J; 2014 Feb; 28(2):998-1009. PubMed ID: 24145720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomal IL-8 derived from Lung Cancer and Colon Cancer cells induced adipocyte atrophy via NF-κB signaling pathway.
    Xiong H; Ye J; Xie K; Hu W; Xu N; Yang H
    Lipids Health Dis; 2022 Dec; 21(1):147. PubMed ID: 36581870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrine improves skeletal muscle atrophy by inhibiting E3 ubiquitin ligases and activating the Akt/mTOR/FoxO3α signaling pathway in C2C12 myotubes and mice.
    Chen L; Chen L; Wan L; Huo Y; Huang J; Li J; Lu J; Xin B; Yang Q; Guo C
    Oncol Rep; 2019 Aug; 42(2):479-494. PubMed ID: 31233199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Toll-Like Receptor/MyD88/XBP1 Signaling Axis Mediates Skeletal Muscle Wasting during Cancer Cachexia.
    Bohnert KR; Goli P; Roy A; Sharma AK; Xiong G; Gallot YS; Kumar A
    Mol Cell Biol; 2019 Aug; 39(15):. PubMed ID: 31138662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saikosaponin D alleviates cancer cachexia by directly inhibiting STAT3.
    Chen LL; Xia LY; Zhang JP; Wang Y; Chen JY; Guo C; Xu WH
    Phytother Res; 2023 Mar; 37(3):809-819. PubMed ID: 36447385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.